Impact of behavioral adherence on clinical improvement and functional status in a diabetes disease management program

Disease Management

Volumn 11, Issue 3, 2008, Pages 169-175

  Wilhide, Calvin ^a   Hayes, John R ^b   Farah, J Ramsay ^c  

^a Nationwide Better Health   (United States)

^b PACIFIC UNIVERSITY   (United States)

^c Calvert Health Partners LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADOLESCENT; ADULT; AGED; ARTICLE; ATTITUDE TO CHANGE; BLOOD PRESSURE; CHILD; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEALTH CARE COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PROSPECTIVE STUDY; QUALITY OF LIFE; STANDARD; STATISTICAL SIGNIFICANCE;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; HEALTH CARE COSTS; HUMANS; INFANT; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES;

EID: 45749105571     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/dis.2007.0021     Document Type: Article

References (12)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329: 977-986.
2. United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed noninsulin dependent diabetes followed for three years. BMJ. 1995;310:83-88.
3. UKPDS 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes. U.K. Prospective Diabetes Study Group. Diabetes Care. 1998;21: 87-92.
4. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317:703-713.
5. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. Jama. Jun 2 1999;281:2005-2012.
6. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;(23 suppl 2): B21-B29.
7. Klein BE, Moss SE, Klein R, Surawicz TS. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology. 1991;98:1261-1265.
8. Jones H, Edwards L, Vallis TM, et al. Changes in diabetes self-care behaviors make a difference in glycemic control: the Diabetes Stages of Change (DiSC) study. Diabetes Care. 2003;26:732-737.
9. Prochaska JO, Norcross JC. Systems of Psychotherapy: A Transtheoretical Analysis. Homewood, Ill: Dorsey Press; 1979.
10. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2003; 26(Suppl 1):S33-S50.
11. Radosevitch D, Pruitt M. Twelve Item Health Status Questionnaire. HSQ-12, Version 2.0. Bloomington, MN: Health Outcomes Institute; 1995.
12. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med. Feb 10 2000;342:381-389.